168 related articles for article (PubMed ID: 32197147)
1. Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series.
Ranjan T; Howard CM; Yu A; Xu L; Aziz K; Jho D; Leonardo J; Hameed MA; Karlovits SM; Wegner RE; Fuhrer R; Lirette ST; Denning KL; Valluri J; Claudio PP
Transl Oncol; 2020 Apr; 13(4):100755. PubMed ID: 32197147
[TBL] [Abstract][Full Text] [Related]
2. Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients' healthcare costs.
Ranjan T; Yu A; Elhamdani S; Howard CM; Lirette ST; Denning KL; Valluri J; Claudio PP
Neurooncol Adv; 2023; 5(1):vdad055. PubMed ID: 37287692
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.
Howard CM; Valluri J; Alberico A; Julien T; Mazagri R; Marsh R; Alastair H; Cortese A; Griswold M; Wang W; Denning K; Brown L; Claudio PP
Transl Oncol; 2017 Apr; 10(2):241-254. PubMed ID: 28199863
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.
Ranjan T; Sengupta S; Glantz MJ; Green RM; Yu A; Aregawi D; Chaudhary R; Chen R; Zuccarello M; Lu-Emerson C; Moulding HD; Belman N; Glass J; Mammoser A; Anderson M; Valluri J; Marko N; Schroeder J; Jubelirer S; Chow F; Claudio PP; Alberico AM; Lirette ST; Denning KL; Howard CM
Cell Rep Med; 2023 May; 4(5):101025. PubMed ID: 37137304
[TBL] [Abstract][Full Text] [Related]
5. Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer.
Howard CM; Bush S; Zgheib NB; Lirette ST; Cortese A; Mollo A; Valluri J; Claudio PP
HSOA J Stem Cells Res Dev Ther; 2021; 7(3):. PubMed ID: 34796266
[TBL] [Abstract][Full Text] [Related]
6. Chemo-predictive assay for targeting cancer stem-like cells in patients affected by brain tumors.
Mathis SE; Alberico A; Nande R; Neto W; Lawrence L; McCallister DR; Denvir J; Kimmey GA; Mogul M; Oakley G; Denning KL; Dougherty T; Valluri JV; Claudio PP
PLoS One; 2014; 9(8):e105710. PubMed ID: 25144312
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer.
Howard CM; Zgheib NB; Bush S; DeEulis T; Cortese A; Mollo A; Lirette ST; Denning K; Valluri J; Claudio PP
Transl Oncol; 2020 Dec; 13(12):100860. PubMed ID: 32862103
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent
de Groot JF; Kim AH; Prabhu S; Rao G; Laxton AW; Fecci PE; O'Brien BJ; Sloan A; Chiang V; Tatter SB; Mohammadi AM; Placantonakis DG; Strowd RE; Chen C; Hadjipanayis C; Khasraw M; Sun D; Piccioni D; Sinicrope KD; Campian JL; Kurz SC; Williams B; Smith K; Tovar-Spinoza Z; Leuthardt EC
Neurooncol Adv; 2022; 4(1):vdac040. PubMed ID: 35611270
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
12. Multifocal high-grade glioma radiotherapy safety and efficacy.
Fleischmann DF; Schön R; Corradini S; Bodensohn R; Hadi I; Hofmaier J; Forbrig R; Thon N; Dorostkar M; Belka C; Niyazi M
Radiat Oncol; 2021 Aug; 16(1):165. PubMed ID: 34454558
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
14. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas.
Haque W; Thong E; Andrabi S; Verma V; Brian Butler E; Teh BS
J Clin Neurosci; 2021 Mar; 85():115-121. PubMed ID: 33581781
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
17. Narrative review of palliative hypofractionated radiotherapy for high grade glioma.
Saeed H; Tseng YD; Lo SS
Ann Palliat Med; 2021 Jan; 10(1):846-862. PubMed ID: 33040565
[TBL] [Abstract][Full Text] [Related]
18. Cervicomedullary tumors in children.
McAbee JH; Modica J; Thompson CJ; Broniscer A; Orr B; Choudhri AF; Boop FA; Klimo P
J Neurosurg Pediatr; 2015 Oct; 16(4):357-66. PubMed ID: 26114990
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.
Lee EQ; Reardon DA; Schiff D; Drappatz J; Muzikansky A; Grimm SA; Norden AD; Nayak L; Beroukhim R; Rinne ML; Chi AS; Batchelor TT; Hempfling K; McCluskey C; Smith KH; Gaffey SC; Wrigley B; Ligon KL; Raizer JJ; Wen PY
Neuro Oncol; 2015 Jun; 17(6):862-7. PubMed ID: 25572329
[TBL] [Abstract][Full Text] [Related]
20. Continuous tamoxifen and dose-dense temozolomide in recurrent glioblastoma.
DI Cristofori A; Carrabba G; Lanfranchi G; Menghetti C; Rampini P; Caroli M
Anticancer Res; 2013 Aug; 33(8):3383-9. PubMed ID: 23898108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
